World TPD & Induced Proximity Summit South Korea 2026

 

The inaugural World TPD & Induced Proximity Summit South Korea is an exclusive opportunity to connect with global pharma, including Astellas and Amgen, leading biotechs such as Ubix Therapeutics and Degron Therapeutics, and local leaders like Tanabe Pharma, FIMECS, and more to develop best-in-class TPD therapeutics.

Featuring key international opinion leaders, deep dives into preclinical and clinical strategy, and expanded content on molecular glues and novel E3 ligases, this summit is your chance to de-risk your pipelines, learn from international experts, and build the global collaborations needed to advance best-in-class TPD therapeutics.

Part of the World Targeted Therapeutics Summit in South Korea by Hanson Wade, this is your opportunity to converge with peers working on antibody-drug conjugates (ADCs), Bispecifics, and T-cell engagers, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics.

More Info

---

---